Journal of Heterocyclic Chemistry p. 229 - 239 (2000)
Update date:2022-08-05
Topics:
Grozinger, Karl G.
Byrne, Denis P.
Nummy, Laurence J.
Ridges, Michael D.
Salvagno, Annette
Nevirapine (1) is a non-nucleoside reverse transcriptase inhibitor marketed for HIV treatment by Boehringer Ingelheim as Viramune since 1996. In vitro studies of nevirapine biotransformation using human liver microsomes demonstrated the formation of five major metabolites. This paper describes the syntheses of these metabolites.
View MoreContact:86-571-87758773
Address:Room604 ,6F, Block A1-3 Xixi Plaza,No. 588 Wenyi West RD, Hangzhou,310012, China
Qingdao Pana-Life Biochem Co.,Ltd.
Contact:86-532-87683902
Address:No.967 Dalao Road, Licang Zone, Qingdao City,Shandong, China 266021
Contact:+86-571-86491666
Address:SHI XIANG ROAD
Zibo Fuxi'er Chemical Co.,Ltd （Shanxian Fuxi'er Chemical Co.,Ltd）
Contact:+86-533-2091422
Address:Eastern 4 on the 3th Road ,Liangxiang Industrial Park, Zibo city ,Shandong,China
Zhejiang Kaili Industrial Co., Ltd
Contact:+86-571-85241926
Address:lantian business center,No.18 Moganshan Road
Doi:10.1016/j.tet.2017.02.061
(2017)Doi:10.1016/S0040-4020(03)00770-1
(2003)Doi:10.1039/b000600i
(2000)Doi:10.1016/j.catcom.2010.02.007
(2010)Doi:10.1039/b807704e
(2008)Doi:10.1002/1521-3765(20010601)7:11<2332::AID-CHEM23320>3.0.CO;2-W
(2001)
